SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · HCA

HCA Healthcare reports THIRD quarter 2026 results

HCA Healthcare, Inc. · Filed · SEC Form 8-K, Item 2.02

HCA Healthcare, Inc. company page Original on SEC.gov ↗

Revenue $19.849 billion +3.6% vs a year ago
EPS $7.27 +3.7% vs a year ago
Guidance revisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue climbed 3.6% year on year to $19.849 billion, and EPS rose 3.7% to $7.27. Sales and earnings both ahead of a year ago is generally the cleaner kind of result. The company revised its guidance; the original release shows which items moved and by how much.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$19.849 billion +3.6% vs a year ago

…Revenues increased 3.6 percent to $19.849 billion…
EPS

$7.27 +3.7% vs a year ago

…Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earnings per share, as adjusted, increased 3.7 percent t…
Guidance

Guidance revised

…The Company’s updated guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company…

Read the original press release on SEC.gov ↗ Filing index ↗

Trend: last 1 reports

All releases →

Revenue growth (YoY)

EPS growth (YoY)

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.